Jean-Sebastien Delisle
Overview
Explore the profile of Jean-Sebastien Delisle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
744
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fajardo-Despaigne J, Lombard-Vadnais F, Pelletier A, Olazabal A, Boutin L, Pasquin S, et al.
Mol Ther Methods Clin Dev
. 2025 Jan;
33(1):101400.
PMID: 39877593
CD4CD8 TCRαβ (double-negative [DN]) T cells represent a rare T cell population that promotes immunological tolerance through various cytotoxic mechanisms. In mice, autologous transfer of DN T cells has shown...
2.
Castonguay M, Bernard L, Corriveau M, Castonguay A, Quenneville G, Cohen S, et al.
Transfusion
. 2025 Jan;
PMID: 39876551
Background: Cold agglutinin disease (CAD) or syndrome (CAS) can be particularly challenging when autologous stem cell transplant (ASCT) is needed. Standard peripheral blood stem cell (PBSC) collection and manipulation involve...
3.
Tanguay M, Cohen S, Menard I, Meunier M, Delisle J, Roy J, et al.
Hematology
. 2025 Jan;
30(1):2448552.
PMID: 39763113
Umbilical cord blood (UCB) represents a valuable graft source in the absence of a human leukocyte antigen (HLA)-matched donor for hematopoietic cell transplantation (HCT). Donor-specific anti-HLA antibodies (DSAs), targeting grafts...
4.
LeBlanc R, Thiant S, Terra R, Ahmad I, Claveau J, Bambace N, et al.
Curr Oncol
. 2024 Nov;
31(11):7258-7274.
PMID: 39590165
Background: To date, the only potential curative treatment for multiple myeloma (MM) remains allogeneic (allo) hematopoietic cell transplant (HCT), although, most patients will eventually relapse. In relapsed patients, donor lymphocyte...
5.
Minden M, Audiger C, Chabot-Roy G, Lesage S, Delisle J, Biemans B, et al.
Ann Transplant
. 2024 Nov;
29:e945249.
PMID: 39497378
BACKGROUND The gastrointestinal (GI) barrier can be damaged by chemotherapy or radiation therapy, causing fatigue, malnutrition, sepsis, dose-limiting toxicity, and, occasionally, death. Glucagon-like peptide-2 (GLP-2) promotes mucosal epithelium growth and...
6.
Roy J, Cohen S, Sauvageau G, Ahmad I, Fournier V, Terra R, et al.
Transplant Cell Ther
. 2024 Oct;
31(1):34.e1-34.e14.
PMID: 39419177
Multiple myeloma (MM) remains associated with a poor outcome, particularly in patients with advanced disease and high-risk (HR) cytogenetics. To date, the only curative treatment is allogeneic (allo) hematopoietic cell...
7.
Caron L, Delisle J, Strong J, Deschambault Y, Lombard-Vadnais F, Labbe A, et al.
Virol J
. 2023 Dec;
20(1):294.
PMID: 38087355
Background: Lymphocytic choriomeningitis virus (LCMV) is a human pathogen naturally present in wild rodents. In addition, LCMV is routinely used in immunology research as a model of viral infection in...
8.
Neault M, Lebert-Ghali C, Fournier M, Capdevielle C, Garfinkle E, Obermayer A, et al.
Cell Rep
. 2023 Sep;
42(9):113084.
PMID: 37716355
Pediatric acute megakaryoblastic leukemia (AMKL) is an aggressive blood cancer associated with poor therapeutic response and high mortality. Here we describe the development of CBFA2T3-GLIS2-driven mouse models of AMKL that...
9.
Cohen S, Bambace N, Ahmad I, Roy J, Tang X, Zhang M, et al.
Blood Adv
. 2023 Jul;
7(19):5717-5726.
PMID: 37467030
Cord blood (CB) transplantation is hampered by low cell dose and high nonrelapse mortality (NRM). A phase 1-2 trial of UM171-expanded CB transplants demonstrated safety and favorable preliminary efficacy. The...
10.
Kabbani D, Yotis D, Ferreira V, Shalhoub S, Belga S, Tyagi V, et al.
Open Forum Infect Dis
. 2023 May;
10(5):ofad200.
PMID: 37213422
Background: Solid organ transplant (SOT) recipients are at risk for severe coronavirus disease 2019 (COVID-19), despite vaccination. Our study aimed to elucidate COVID-19 vaccine immunogenicity and evaluate adverse events such...